ImportRefusal LogoImportRefusal

Contacare Ophthalmics & Diagnostics

⚠️ High Risk

FEI: 3006217304 • Dabhasa, Gujarat • INDIA

FEI

FEI Number

3006217304

📍

Location

Dabhasa, Gujarat

🇮🇳

Country

INDIA
🏢

Address

310b Village Sim, Block No, Dabhasa, Gujarat, India

High Risk

FDA Import Risk Assessment

59.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

18
Total Refusals
12
Unique Violations
1/22/2025
Latest Refusal
11/8/2007
Earliest Refusal

Score Breakdown

Violation Severity
69.0×40%
Refusal Volume
47.4×30%
Recency
80.7×20%
Frequency
10.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1186×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

274×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

3412×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

2372×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

781×

STERILITY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to have been prepared, packed or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.

30811×

INVDEVICE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a device for investigational use for which no exemption has been granted as prescribed by Section 520(g)

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

37611×

FILTH

The article is subject to refusal of admission pursuant to section 801(a)(3) of the FD&C Act in that the article contains potentially hazardous, or otherwise objectionable in light of intended use, microbial adulteration and therefore consists in part of a filthy substance

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
1/22/2025
86LZPAID, SURGICAL, VISCOELASTIC
118NOT LISTED
237NO PMA
3280FRNMFGREG
341REGISTERED
508NO 510(K)
Division of Southeast Imports (DSEI)
5/2/2018
86PMWSTRABISMUS DETECTION DEVICE
3081INVDEVICE
Division of Southeast Imports (DSEI)
1/19/2018
63XBD12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
27DRUG GMPS
Division of Northern Border Imports (DNBI)
1/19/2018
63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
27DRUG GMPS
Division of Northern Border Imports (DNBI)
1/19/2018
63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
27DRUG GMPS
Division of Northern Border Imports (DNBI)
1/9/2018
63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
3761FILTH
Division of Northern Border Imports (DNBI)
6/23/2017
65RAK19SODIUM CHLORIDE (REPLENISHER)
78STERILITY
Division of Southwest Imports (DSWI)
4/21/2014
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
75UNAPPROVED
Chicago District Office (CHI-DO)
4/21/2014
66VDK99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
75UNAPPROVED
Chicago District Office (CHI-DO)
3/7/2014
63XCY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
75UNAPPROVED
Chicago District Office (CHI-DO)
7/12/2013
63XIY99DIAGOSTIC AID (DRUGS) N.E.C.
75UNAPPROVED
Chicago District Office (CHI-DO)
11/9/2012
61KCK62HOMATROPINE HYDROBROMIDE (A-CHOLINERGIC)
118NOT LISTED
27DRUG GMPS
75UNAPPROVED
Chicago District Office (CHI-DO)
9/14/2012
78MRESOLUTION, SODIUM HYALURONATE
237NO PMA
New Orleans District Office (NOL-DO)
9/14/2012
63XDK99DIAGOSTIC AID (DRUGS) N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/14/2012
63XCP12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/14/2012
88LGYTRYPAN BLUE
118NOT LISTED
New Orleans District Office (NOL-DO)
4/23/2012
63XCY99DIAGOSTIC AID (DRUGS) N.E.C.
333LACKS FIRM
San Juan District Office (SJN-DO)
11/8/2007
86LWLFLUID, INTRAOCULAR
118NOT LISTED
341REGISTERED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Contacare Ophthalmics & Diagnostics's FDA import refusal history?

Contacare Ophthalmics & Diagnostics (FEI: 3006217304) has 18 FDA import refusal record(s) in our database, spanning from 11/8/2007 to 1/22/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Contacare Ophthalmics & Diagnostics's FEI number is 3006217304.

What types of violations has Contacare Ophthalmics & Diagnostics received?

Contacare Ophthalmics & Diagnostics has been cited for 12 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Contacare Ophthalmics & Diagnostics come from?

All FDA import refusal data for Contacare Ophthalmics & Diagnostics is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.